Study identifier:NIS-OHU-ARI-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Survey and follow-up of the treatment adherence and medication habits of early breast cancer patients on adjuvant hormonal therapy with the aromatase inhibitor Arimidex
Breast Cancer
-
No
-
Female
1077
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
The aim of this study is to assess the patient's perception about and willingness to take his or her medication and the influencing factors interfering with taking medication.
Location
Location
Balatonfoldvar, Hungary
Location
Bekescsaba, Hungary
Location
Budapest, Hungary
Location
Debrecen, Hungary
Location
Dombovar, Hungary
Location
Gyongyos, Hungary
Location
Gyor, Hungary
Location
Gyula, Hungary
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.